Avaliação de neuropatia sensitiva motora do pé de pacientes portadores de Diabetes Mellitus tipo 2 atendidos em unidades de saúde de Vila Velha e Centro de Especialidades Médicas e Atenção à Saúde (CEMAS) / Evaluation of motor sensory neuropathy of the foot of patients with type 2 Diabetes Mellitus treated at health units in Vila Velha and a Center for Medical Specialties and Health Care

Introdução: O pé diabético é conceituado no glossário do Consenso Internacional como infecção, ulceração e/ou destruição de tecidos moles associados a alterações neurológicas e vários graus de doença arterial periférica (DAP) nos membros inferiores. Objetivo: Avaliar a neuropatia sensitiva motora do pé de 52 pacientes portadores do diabetes mellitus tipo 2 participantes do HIPERDIA das Unidades de Saúde de Vila Nova, Ibes e do CEMAS. Método: Foi aplicado um questionário avaliando fatores de risco para ulceração dos pés como: polineuropatia periférica (PND), deformidades (PND motora, biodinâmica, limitação da mobilidade articular), trauma, doença arterial periférica (DAP), histórico de úlcera e/ou histórico de amputação, nefropatia, retinopatia, morar sozinho, inacessibilidade ao sistema de saúde. Além disso, foi realizado exame físico para avaliar a sensibilidade protetora plantar utilizando monofilamento de náilon de 10 g, diapasão 128Hz para estímulo de vibração em saliência óssea, palito para avaliação de dor em qualquer ponto plantar e martelo para avaliação dos reflexos tendíneos (Aquileu). Resultados e Discussão: Foram avaliados 52 pacientes, dos quais 63,46% eram mulheres e 36,54% homens com a faixa etária entre 44 a 89 anos, tendo como idade média 64,65 ± 8,79 anos. Todos tinham acesso ao Sistema Único de Saúde (SUS), 38,46% já tinham neuropatia instalada e dentre os 61,54% restantes, que não possuíam neuropatia, apenas 6,25% foram classificados com perda da sensibilidade protetora plantar. Conclusão: Diante do exposto, destaca-se a importância do atendimento primário no setor de saúde, por meio da ampliação das ações básicas direcionadas aos cuidados com o diabetes, levando em consideração a alta porcentagem de diabéticos com neuropatia já instalada, afim de prevenir possíveis complicações em membros inferiores de pacientes que ainda não possuem neuropatias e a implementação de medidas de tratamento com a finalidade de diminuir o avanço das complicações em pacientes que já as possuem

Colicistite aguda alitiásica condutas que reduzem a taxa de internação em Terapia de Unidade Intensiva: uma revisão sistemática: Acute althiasic cholicistitis conducts that reduce the hospitalization rate in Intensive Unit Therapy: a systematic review

Os cálculos biliares se encontram em mais de 10% da população mundial, sendo que esta incidência se torna maior com o avanço da idade. Sendo assim a colecistite pode ser considerada como uma emergência comum no mundo, sendo que na maior parte dos casos é decorrente da inflamação da parede interna da vesícula devido á impactação do cálculo e decorrente obstrução no ducto cístico, produzindo assim dor repentina e aguda, entretanto a colecistite aguda alitiásica ocorre sem que haja cálculos em seu interior. Esse trabalho possui como sua pergunta de pesquisa qual conduta deve ser adotada para reduzir a taxa de internação em UTI’s em pacientes que apresentem colicistite aguda alitiásica. E assim como seu objetivo geral demonstrar a conduta adequada para manejo de pacientes que apresentem colicistite aguda alitiásica. E como seus objetivos específicos: Identificar do que se trata um quadro de colicistite aguda alitiásica; Auxiliar na tomada de conduta pelos profissionais acerca do tratamento adequado; Disponibilizar informações acerca do assunto. Esse trabalho trata-se de uma revisão sistemática de artigos extraídos das plataformas do PubMed, BVS, Lilacs, Medline, Scielo, esses que possuem datas dos últimos 5 anos e escritos nos seguintes idiomas: português, inglês e espanhol. Com isso conclui-se que ainda são escassos os estudos acerca do tema, portanto é necessário que os médicos consigam de forma significativa o diagnóstico com agilidade, e para isso o conhecimento sobre assunto por uma equipe multidisciplinar deve ser amplamente desenvolvido

Pervasive gaps in Amazonian ecological research

Biodiversity loss is one of the main challenges of our time,1,2 and attempts to address it require a clear un derstanding of how ecological communities respond to environmental change across time and space.3,4 While the increasing availability of global databases on ecological communities has advanced our knowledge of biodiversity sensitivity to environmental changes,5–7 vast areas of the tropics remain understudied.8–11 In the American tropics, Amazonia stands out as the world’s most diverse rainforest and the primary source of Neotropical biodiversity,12 but it remains among the least known forests in America and is often underrepre sented in biodiversity databases.13–15 To worsen this situation, human-induced modifications16,17 may elim inate pieces of the Amazon’s biodiversity puzzle before we can use them to understand how ecological com munities are responding. To increase generalization and applicability of biodiversity knowledge,18,19 it is thus crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple or ganism groups in a machine learning model framework to map the research probability across the Brazilian Amazonia, while identifying the region’s vulnerability to environmental change. 15%–18% of the most ne glected areas in ecological research are expected to experience severe climate or land use changes by 2050. This means that unless we take immediate action, we will not be able to establish their current status, much less monitor how it is changing and what is being lostinfo:eu-repo/semantics/publishedVersio

Pervasive gaps in Amazonian ecological research

Biodiversity loss is one of the main challenges of our time,1,2 and attempts to address it require a clear understanding of how ecological communities respond to environmental change across time and space.3,4 While the increasing availability of global databases on ecological communities has advanced our knowledge of biodiversity sensitivity to environmental changes,5,6,7 vast areas of the tropics remain understudied.8,9,10,11 In the American tropics, Amazonia stands out as the world's most diverse rainforest and the primary source of Neotropical biodiversity,12 but it remains among the least known forests in America and is often underrepresented in biodiversity databases.13,14,15 To worsen this situation, human-induced modifications16,17 may eliminate pieces of the Amazon's biodiversity puzzle before we can use them to understand how ecological communities are responding. To increase generalization and applicability of biodiversity knowledge,18,19 it is thus crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple organism groups in a machine learning model framework to map the research probability across the Brazilian Amazonia, while identifying the region's vulnerability to environmental change. 15%–18% of the most neglected areas in ecological research are expected to experience severe climate or land use changes by 2050. This means that unless we take immediate action, we will not be able to establish their current status, much less monitor how it is changing and what is being lost

Clinical, epidemiological, and therapeutic profile of dermatophytosis

BACKGROUND: The cutaneous mycoses, mainly caused by dermatophyte fungi, are among the most common fungal infections worldwide. It is estimated that 10% to 15% of the population will be infected by a dermatophyte at some point in their lives, thus making this a group of diseases with great public health importance. OBJECTIVE: To analyze the clinical, epidemiological, and therapeutic profile of dermatophytosis in patients enrolled at the Dermatology service of Universidade do Estado do Pará, Brazil, from July 2010 to September 2012. METHOD: A total of 145 medical records of patients diagnosed with dermatophytosis were surveyed. Data were collected and subsequently recorded according to a protocol developed by the researchers. This protocol consisted of information regarding epidemiological and clinical aspects of the disease and the therapy employed. RESULTS: The main clinical form of dermatophyte infection was onychomycosis, followed by tinea corporis, tinea pedis, and tinea capitis. Furthermore, the female population and the age group of 51 to 60 years were the most affected. Regarding therapy, there was a preference for treatments that combine topical and systemic drugs, and the most widely used drugs were fluconazole (systemic) and ciclopirox olamine (topical). CONCLUSION: This study showed the importance of recurrent analysis of the epidemiological profile of dermatophytosis to enable correct therapeutic and preventive management of these conditions, which have significant clinical consequences, with chronic, difficult-totreat lesions that can decrease patient quality of life and cause disfigurement

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes. These guidelines are not meant to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question being asked and the system being used. Moreover, no individual assay is perfect for every situation, calling for the use of multiple techniques to properly monitor autophagy in each experimental setting. Finally, several core components of the autophagy machinery have been implicated in distinct autophagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block autophagy should rely on targeting two or more autophagy-related genes that ideally participate in distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical innovation in the field